3D bioprinting

Induced Pluripotent Stem Cell (iPSC) Industry Market Size, Trends, and Forecast Report - ResearchAndMarkets.com

Retrieved on: 
화요일, 5월 7, 2024
Health, Stem Cells, OA, Cellular Dynamics International, University, Microsoft Exchange Server, Cell, CRISPR, Safety, Drug development, Osteoarthritis, World Games, MSC, Partnership, Research, CLI, B cell, Application, Disease, Human, Therapy, Patient, COVID-19, Tissue engineering, Graft-versus-host disease, IPSC, Medicine, Kyoto University, 3D bioprinting, Macular degeneration, Regenerative medicine, CDI, Clinical trial, Toxicology, Drug discovery, Personalized medicine, Merck, Thermo Fisher Scientific, Pharmaceutical industry

The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • Since the discovery of induced pluripotent stem cell (iPSC) technology in 2006, significant progress has been made in stem cell biology and regenerative medicine.
  • Today, methods of commercializing induced pluripotent stem cells (iPSCs) include:
    Cellular Therapy: iPSCs are being explored in a diverse range of cell therapy applications for the purpose of reversing injury or disease.
  • This global strategic report reveals all major market competitors worldwide, including their core technologies, strategic partnerships, and products under development.

Global Synthetic Biology Market Research 2024-2035: Metabolic Engineering, Genome Engineering, Gene Synthesis, Protein Engineering, Synthetic Genomics, Cell-free Systems, and More - ResearchAndMarkets.com

Retrieved on: 
화요일, 4월 30, 2024
Health, Biotechnology, PHA, Textile, Synthetic biology, Cas9, Biohydrogen, Methane, Zinc finger nuclease, SWOT, Alcohol, Genetic engineering, Biopolymer, Building material, Biofuel, Protein engineering, Biomass, Engineering, Biocatalysis, Science, Polymer, Metabolic engineering, PLA, 3D bioprinting, Plastic, Market, Biology, Gas, CO2, Acid, Fermentation, Organization, Retail

This in-depth report provides a comprehensive analysis of the rapidly evolving synthetic biology market and its transformative impact across major industries.

Key Points: 
  • This in-depth report provides a comprehensive analysis of the rapidly evolving synthetic biology market and its transformative impact across major industries.
  • Synthetic biology is an interdisciplinary field that combines science and engineering, applying the principles and tools of engineering to biology.
  • Key synthetic biology tools and techniques are analyzed in detail, including metabolic engineering, genome engineering (CRISPR/Cas9, TALENs, ZFNs), gene synthesis, protein engineering, synthetic genomics, cell-free systems, and more.
  • Forecasts are provided for the overall synthetic biology market revenues from 2018 to 2035, segmented by region and individual market verticals like biofuels, biochemicals, bioplastics, etc.

Redwire Signs MOU with Boryung to Support its Trailblazing Humans In Space Program for Global Human Health

Retrieved on: 
수요일, 4월 24, 2024
Other Manufacturing, Research, Technology, Engineering, Satellite, Other Technology, Aerospace, Manufacturing, Science, Other Science, RDW, Redwire, ISS, MOU, Investment, Corporation, International Space Station, Health, NASA, Partnership, Human, Space research, 3D bioprinting, Civilization, Knowledge, Pharmaceutical industry

Through the agreement, Redwire will serve as an implementation partner in support of Boryung’s Humans In Space program, a global initiative committed to advancing knowledge and innovation that support the well-being of humanity through space experiments.

Key Points: 
  • Through the agreement, Redwire will serve as an implementation partner in support of Boryung’s Humans In Space program, a global initiative committed to advancing knowledge and innovation that support the well-being of humanity through space experiments.
  • Boryung’s Humans In Space program represents a significant opportunity to advance space research and development to accelerate novel developments that can lead to improvements in human health and eventually enable the realization of an interplanetary civilization.
  • Through the MOU, Redwire intends to facilitate research experiments on-orbit, funded through the Humans In Space program, and provide mission management services.
  • Redwire will also serve as a partner for the third annual Humans In Space challenge, a global competition for researchers and innovators addressing the impact of space on human well-being.

Feinstein Institutes’ Daniel A. Grande Named President-Elect of the International Cartilage Regeneration & Joint Preservation Society (ICRS)

Retrieved on: 
목요일, 4월 18, 2024
Health, Hospitals, Other Health, Other Science, General Health, Research, Science, Education, FDA, Rheumatology, EVS, Microsoft Exchange Server, Intervertebral disc, Regenerative medicine, Seminal vesicles, Cartilage, Doctor of Philosophy, B cell, Meniscus, ICRS, Patient, Tissue engineering, Molecular medicine, 3D bioprinting, Medical research, Microsoft Access, Multimedia, Regeneration, Stem cell, Credit, Journal, Medical device

The International Cartilage Regeneration & Joint Preservation Society (ICRS) has named Daniel A. Grande, PhD, assistant vice president of research services and professor of molecular medicine and orthopedic surgery at The Feinstein Institutes for Medical Research , its new President-Elect.

Key Points: 
  • The International Cartilage Regeneration & Joint Preservation Society (ICRS) has named Daniel A. Grande, PhD, assistant vice president of research services and professor of molecular medicine and orthopedic surgery at The Feinstein Institutes for Medical Research , its new President-Elect.
  • View the full release here: https://www.businesswire.com/news/home/20240418363701/en/
    Feinstein Institutes’ Dr. Daniel A. Grande has been named the new president-elect of International Cartilage Repair Society.
  • (Credit: Feinstein Institutes)
    Dr. Grande, renowned for his significant contributions to cartilage repair and regeneration, will lead the ICRS in its mission to advance science and education in preventing and treating cartilage injuries.
  • "I am honored and excited to serve as the President-Elect of the International Cartilage Regeneration & Joint Preservation Society.

Arrayjet’s ArrayPlex Platform Selected by Immunome for Use in Its Discovery of Targeted Cancer Therapies

Retrieved on: 
월요일, 3월 18, 2024
Oncology, Health, Medical Devices, Research, Science, Pharmaceutical, Biotechnology, Partnership, 3D bioprinting, Library, Knowledge, Cancer, ELISA, Antibody, Immunome, Mobile phone

Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that its ArrayPlex™ discovery platform has been selected by Immunome, Inc. (NASDAQ: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, to expand its in-house high-throughput screening tools.

Key Points: 
  • Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that its ArrayPlex™ discovery platform has been selected by Immunome, Inc. (NASDAQ: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, to expand its in-house high-throughput screening tools.
  • ArrayPlex was created by Arrayjet to meet the unique assay requirements of its customers for high-throughput screening services and tools.
  • During Arrayjet’s successful seven-year partnership with Immunome, Arrayjet performed screening services using the ArrayPlex platform, and the platform underwent further optimisation, most recently to integrate internal assay controls and enhanced data normalisation.
  • Arrayjet is pleased that Immunome has now chosen to purchase an instrument and internalise the ArrayPlex assay as an in-house, high-throughput screening resource in its efforts to discover targeted cancer therapies.

NurExone’s Intellectual Property Portfolio Expands

Retrieved on: 
화요일, 2월 20, 2024
EVS, EV, Exosome, 3D, NRX, PCT, Cell, B cell, RNA, Patent, 3D bioprinting, IP, Intellectual property, Seminal vesicles, Fine chemical

TORONTO and HAIFA, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, proudly underscores its expanding Intellectual Property (IP) portfolio, which will serve as the foundation for its strategic goal of licensing the innovative ExoTherapy platform to interested biotech companies.

Key Points: 
  • TORONTO and HAIFA, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, proudly underscores its expanding Intellectual Property (IP) portfolio, which will serve as the foundation for its strategic goal of licensing the innovative ExoTherapy platform to interested biotech companies.
  • NurExone’s Intellectual property portfolio describes the ExoTherapy platform’s comprehensive technology and processes for the production of nanodrugs including large scale production of exosomes, loading of active molecules and the composition of the exosomes themselves.
  • The loading technology was presented to the public in the press release of February 12, 2024.
  • Aspects of the company’s platform which relate to Extracellular Vesicles (EVs) production are described in a growing intellectual property portfolio with two PCT applications currently in National Phases.

CollPlant Issues Letter to Shareholders

Retrieved on: 
목요일, 2월 15, 2024
Therapy, United Nations Global Compact, CLGN, Cancer, Ulcerative colitis, Regeneration, Regenerative medicine, Inflammatory Bowel Diseases, Breast augmentation, Polymerization, 3D, Patent, Social, AbbVie, Connective tissue, Drug discovery, ESG, Letter, 3D bioprinting, Epidermis, Breast, Genetic engineering, Safety, UC, Stratasys, Hyaluronic acid, Ecosystem, Patient, Medicine, Environment, Tissue

Our long-term collaboration with AbbVie to develop a paradigm-shifting regenerative dermal and soft tissue filler continues to advance.

Key Points: 
  • Our long-term collaboration with AbbVie to develop a paradigm-shifting regenerative dermal and soft tissue filler continues to advance.
  • In June of last year, we announced the achievement of an important milestone under this collaboration which triggered a $10 million payment from AbbVie to CollPlant.
  • Per CollPlant's agreement with AbbVie, CollPlant has the potential to receive additional milestones and option products payments, as well as receive meaningful royalties on product sales.
  • In the second quarter of 2023, CollPlant hired a dedicated expert to lead our Environment, Social and Governance (ESG) effort.

Global Tissue Engineering Research Analysis Report 2023: Market to Reach $8.9 Billion by 2028, Driven by Rising Funding and Investments and Advancements in Regenerative Medicines - ResearchAndMarkets.com

Retrieved on: 
목요일, 2월 8, 2024
Manufacturing, Other Health, Stem Cells, Pharmaceutical, Medical Devices, Hospitals, Genetics, Cardiology, Science, Biotechnology, Other Science, Health, Engineering, Research, Medical Supplies, Government of India, Scaffolding, Investment, Growth, Accident, B cell, Collagen, Trauma, Orthopedic surgery, Regeneration, Biology, Tissue engineering, Inspiration, DST, 3D bioprinting, Market development, USD, Pharmaceutical industry

The global tissue engineering market is projected to reach USD 8.9 billion by 2028 from an estimated USD 4.4 billion in 2023, at a CAGR of 15.3%

Key Points: 
  • The global tissue engineering market is projected to reach USD 8.9 billion by 2028 from an estimated USD 4.4 billion in 2023, at a CAGR of 15.3%
    The growth of this market can be attributed to rising funding and investments for the development of advanced tissue engineering solutions and growing technological advancements in regenerative medicines.
  • The synthetic material segment accounted for the largest share of material in the global tissue engineering market in 2022.
  • The increasing advancements in cell therapies and regenerative medicines are promoting the growth of the tissue engineering market in the region.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the tissue engineering market.

3D Printing Technology is Making it Possible for Each Patient to Get Personalized Brackets

Retrieved on: 
월요일, 2월 5, 2024
Competitive landscape, Growth, Knowledge, Patient satisfaction, Research, FMI, Orthodontics, 3D, Patient, Overalls, Ecosystem, Dental, Artificial intelligence, Brace, Associate, 3D bioprinting, Printing, Organization, Dentistry

NEWARK, Del., Feb. 5, 2024 /PRNewswire/ -- The 3D-Printed Dental Brace Market is anticipated to be valued at US$ 395.6 million in 2024, with a compound annual growth rate (CAGR) of 4.8% between 2024 and 2034. Due to the surging popularity of teeth-strengthening aligners, the market is expected to reach US$ 633.9 million by 2034.

Key Points: 
  • Integrating 3D printing technology has played a crucial role in facilitating this trend.
  • The ongoing advancement of 3D printing technology has completely transformed the production method for dental braces.
  • Global patient awareness and the globalization of these trends have propelled the widespread use of 3D printed dental braces, completely changing the orthodontic market."
  • While dental labs include 3D printing in their processes, research and development organizations are the driving forces behind innovation in materials and printing technology.

3D Printing Technology is Making it Possible for Each Patient to Get Personalized Brackets

Retrieved on: 
월요일, 2월 5, 2024
Competitive landscape, Growth, Knowledge, Patient satisfaction, Research, FMI, Orthodontics, 3D, Patient, Overalls, Ecosystem, Dental, Artificial intelligence, Brace, Associate, 3D bioprinting, Printing, Organization, Dentistry

NEWARK, Del., Feb. 5, 2024 /PRNewswire/ -- The 3D-Printed Dental Brace Market is anticipated to be valued at US$ 395.6 million in 2024, with a compound annual growth rate (CAGR) of 4.8% between 2024 and 2034. Due to the surging popularity of teeth-strengthening aligners, the market is expected to reach US$ 633.9 million by 2034.

Key Points: 
  • Integrating 3D printing technology has played a crucial role in facilitating this trend.
  • The ongoing advancement of 3D printing technology has completely transformed the production method for dental braces.
  • Global patient awareness and the globalization of these trends have propelled the widespread use of 3D printed dental braces, completely changing the orthodontic market."
  • While dental labs include 3D printing in their processes, research and development organizations are the driving forces behind innovation in materials and printing technology.